TT insider sale filed: 19,361 shares via UBS on 08/13/2025

Rhea-AI Filing Summary

Trane Technologies plc (TT) has filed a Form 144 notifying a proposed sale of 19,361 common shares with an aggregate market value of $8,544,009.30, to be sold on the NYSE on 08/13/2025 through UBS Financial Services.

The filing lists the origins of the shares as compensation-related grants and exercises: a stock-option exercise on 08/13/2025 for 15,125 shares (cash paid), performance stock units (PSUs) and restricted stock units (RSUs) granted on multiple dates in 2024 and 2025 totaling the remaining shares. The filer reports nothing to report for securities sold in the past three months and includes the standard representation that the filer does not possess undisclosed material adverse information.

Positive

• Full acquisition history disclosed: Each lot lists date, acquisition type (RSU, PSU, stock option exercise) and issuer as source.
• No reported sales in the past three months, per the form's "Nothing to Report" entry.
• Broker identified for the transaction: UBS Financial Services with address included, supporting orderly execution.

Negative

• Insider intends to sell 19,361 shares with an aggregate market value of $8,544,009.30 on 08/13/2025.
• Large single-day sale planned through the NYSE which may be interpreted by some market participants as insider liquidity activity.

Insights

Financial Analyst

TL;DR: Routine insider sale notice: 19,361 shares ($8.54M) tied to compensation receipts and a same-day option exercise, filed under Rule 144.

This Form 144 documents an expected sale of 19,361 common shares on 08/13/2025 through UBS Financial Services with an aggregate market value of $8,544,009.30. The securities originated from grants and an option exercise issued by the company, suggesting these are compensation-related holdings being liquidated rather than secondary transfers from unrelated third parties. The filing also states no reported sales in the prior three months and includes the required attestation regarding material nonpublic information. For investors, this is a disclosure of insider selling activity; it is procedural rather than transformative to the company’s operational outlook.

Corporate Governance Expert

TL;DR: Disclosure conforms to Rule 144 norms; sale is documented and tied to compensation, with the filer attesting no undisclosed material information.

The Form 144 provides required details: broker (UBS Financial Services), number of shares to be sold (19,361), aggregate market value ($8,544,009.30), scheduled sale date (08/13/2025), and acquisition history showing RSUs, PSUs and an option exercise from the issuer. The filing includes the standard signature representation about material adverse information and notes no securities sold in the prior three months. This is a governance-compliance disclosure; its primary implication is transparency about insider liquidity rather than a governance concern unless subsequent filings show further material changes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010	19361	8544009.30	222515359	08/13/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/13/2025	Stock option exercise	Issuer			15125	08/13/2025	Cash
Common	03/03/2025	PSU	Issuer			2531	03/03/2025	NA
Common	02/07/2025	RSU	Issuer			289	02/07/2025	NA
Common	02/06/2025	RSU	Issuer			227	02/06/2025	N/A
Common	02/01/2025	RSU	Issuer			289	02/01/2025	N/A
Common	02/08/2024	RSU	Issuer			325	02/08/2024	N/A
Common	02/07/2024	RSU	Issuer			287	02/07/2024	N/A
Common	02/01/2024	RSU	Issuer			288	02/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Trane Technologies (TT) report on this Form 144?

The Form 144 notifies a proposed sale of 19,361 common shares with an aggregate market value of $8,544,009.30 to be sold on 08/13/2025 on the NYSE through UBS Financial Services.

Who is acting as broker for the TT sale?

The broker listed is UBS Financial Services, Inc., Eleven Madison Avenue, 4th Floor, New York, NY 10010.

Where did the shares being sold come from?

The filing shows the shares were acquired from the issuer via a stock option exercise (15,125 shares on 08/13/2025) and through PSU and RSU grants on various dates in 2024 and 2025.

Has the filer sold any issuer securities in the past three months?

No. The Form 144 entry for securities sold during the past three months states: Nothing to Report.

Does the filer attest to possession of material nonpublic information?

Yes. By signing the notice the filer represents they do not know any material adverse information regarding the issuer that has not been publicly disclosed.